论文部分内容阅读
目的观察痰热清与阿奇霉素联合治疗支原体肺炎的临床疗效。方法将我院收治的78例支原体肺炎患者实行分组研究,分成39例的研究组采用痰热清与阿奇霉素联合治疗,39例对照组采用阿奇霉素治疗,并对比分析两组的临床疗效。结果研究组患者的治疗总有效率为92.31%,呼吸困难和咳嗽等临床症状恢复效果好,明显优于对照组的71.79%;各项临床症状恢复所需时间均少于对照组;复发情况也少于对照组,二者组间比较均具有统计学意义(P<0.05)。结论将痰热清与阿奇霉素联合治疗支原体肺炎,能帮助患者尽快减轻临床症状,治疗效果显著,且复发情况较少,值得推广。
Objective To observe the clinical efficacy of Tanreqing combined with azithromycin in the treatment of mycoplasma pneumonia. Methods 78 cases of Mycoplasma pneumonia admitted to our hospital were divided into three groups: 39 cases were treated with Tanreqing and azithromycin, 39 cases were treated with azithromycin, and the clinical efficacy was compared between the two groups. Results The total effective rate of study group was 92.31%. The recovery of clinical symptoms such as dyspnea and cough was better than 71.79% of the control group. The recovery time of clinical symptoms was less than that of the control group. The recurrence rate Less than the control group, the two groups were statistically significant (P <0.05). Conclusion Tanreqing and azithromycin combined treatment of mycoplasma pneumonia, can help patients reduce clinical symptoms as soon as possible, the treatment effect is significant, and less recurrence, it is worth promoting.